Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Glutamine Supplementation in Duchenne Muscular Dystrophy
NCT00296621Phase 2Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Feb 2006
- Primary completion
- Feb 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of glutamine in Duchenne muscular dystrophy (DMD) (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Walking speed on a standard course at 9 months. Started Feb 2006; status: completed.
02
Drugs
glutamine
03
Conditions
Duchenne muscular dystrophy (DMD)
Beyond the preview
Go deeper on NCT00296621.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00296621.